Spiolto Respimat (olodaterol tiotropium bromide): Reviews and patient testimonials


/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1720004028

Back Back to the list of medications

Medication indications

Spiolto Respimat 2.5 microgram/2.5 microgram, inhalation solution

Spiolto Respimat is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).


Route of administration: opinion.traitement.inhalation
Molecule: olodaterol, tiotropium bromide

Patients' opinions on Spiolto Respimat

In brief

General satisfaction level: 7.00/10 Learn more

Treatment's effectiveness: 7.00/10 Learn more

Ease of use: 10.00/10 Learn more

Adherence to prescription: 10.00/10 Learn more

Detected side effects: 6.00/10 Learn more

Improvement in the quality of life: 7.00/10 Learn more

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community

Join Carenity and be the first to give your opinion on this medication.

Conditions related to this medication

Fact sheet

COPD

See the fact sheet